WonderTx
YC S26San Francisco, US · 3 employees · 1 known investors
WonderTx is an AI-native biotech that develops extrapolative AI models to discover oral drug molecules for targets with validated human biology that currently lack a viable pill-based treatment. The company aims to convert injectable therapies into pills and works on both its own and partner drug discovery programs.
Also known as A Company in Stealth Mode Incorporated
AI & Machine LearningBiotechHealthtechAI-powered Drug DiscoveryGenerative AIUnited States of AmericaAmerica / CanadaFully Remote
Founders & leadership· Y Combinator alumni (S26)
AH
Abraham Heifetsin𝕏FounderAbraham Heifets is founder and CEO of WonderTx and previously co-founded Atomwise, an AI-driven drug discovery company. He earned a PhD from the University of Toronto, worked at IBM Research, is named on 15 patents and applications, and contributed AI work to Cornell's robotic soccer team.
Investors · 1
The YC application· Summer 2026 batch
Alumni Q&A
- What is your long-term vision? If you truly succeed, what will be different about the world?
- The founders aim to integrate AI throughout every stage of drug discovery, making the path from concept to clinic tractable for hard-to-treat diseases. Their intended outcome is longer, better lives for patients whose conditions currently cannot be drugged effectively.
Summarized from the founders' answers on their Y Combinator profile.
Frequently asked questions
- What does WonderTx do?
- WonderTx is an AI-native biotech that develops extrapolative AI models to discover oral drug molecules for targets with validated human biology that currently lack a viable pill-based treatment. The company aims to convert injectable therapies into pills and works on both its own and partner drug discovery programs.
- Who founded WonderTx?
- WonderTx was founded by Abraham Heifets.
- Who are WonderTx's investors?
- WonderTx's investors include Y Combinator.
- Where is WonderTx headquartered?
- WonderTx is headquartered in San Francisco, US.